| A transmembrane intracellular estrogen receptor mediates rapid cell signaling CM Revankar, DF Cimino, LA Sklar, JB Arterburn, ER Prossnitz Science 307 (5715), 1625-1630, 2005 | 2773 | 2005 |
| Virtual and biomolecular screening converge on a selective agonist for GPR30 CG Bologa, CM Revankar, SM Young, BS Edwards, JB Arterburn, ... Nature chemical biology 2 (4), 207-212, 2006 | 925 | 2006 |
| GPR30: a novel indicator of poor survival for endometrial carcinoma HO Smith, KK Leslie, M Singh, CR Qualls, CM Revankar, NE Joste, ... American journal of obstetrics and gynecology 196 (4), 386. e1-386. e11, 2007 | 291 | 2007 |
| Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30 CM Revankar, HD Mitchell, AS Field, R Burai, C Corona, C Ramesh, ... ACS Chemical Biology 2 (8), 536-544, 2007 | 207 | 2007 |
| Arrestins block G protein-coupled receptor-mediated apoptosis CM Revankar, CM Vines, DF Cimino, ER Prossnitz Journal of Biological Chemistry 279 (23), 24578-24584, 2004 | 157 | 2004 |
| N-formyl peptide receptors internalize but do not recycle in the absence of arrestins CM Vines, CM Revankar, DC Maestas, LL LaRusch, DF Cimino, ... Journal of Biological Chemistry 278 (43), 41581-41584, 2003 | 144 | 2003 |
| Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine2B receptor agonists: implications for drug safety assessment XP Huang, V Setola, PN Yadav, JA Allen, SC Rogan, BJ Hanson, ... Molecular pharmacology 76 (4), 710-722, 2009 | 136 | 2009 |
| Calmodulin modulates Akt activity in human breast cancer cell lines CM Coticchia, CM Revankar, TB Deb, RB Dickson, MD Johnson Breast cancer research and treatment 115, 545-560, 2009 | 82 | 2009 |
| Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) Chelates C Ramesh, BJ Bryant, T Nayak, CM Revankar, T Anderson, KE Carlson, ... Journal of the American Chemical Society 128 (45), 14476-14477, 2006 | 50 | 2006 |
| Utilization of the TangoTM β-Arrestin Recruitment Technology for Cell-Based EDG Receptor Assay Development and Interrogation JA Wetter, C Revankar, BJ Hanson Journal of Biomolecular screening 14 (9), 1134-1141, 2009 | 46 | 2009 |
| A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment BJ Hanson, J Wetter, MR Bercher, L Kopp, M Fuerstenau-Sharp, ... SLAS Discovery 14 (7), 798-810, 2009 | 42 | 2009 |
| Adaptor Protein‐2 Interaction with Arrestin Regulates GPCR Recycling and Apoptosis BM Wagener, NA Marjon, CM Revankar, ER Prossnitz Traffic 10 (9), 1286-1300, 2009 | 37 | 2009 |
| A selective ligand for estrogen receptor proteins discriminates rapid and genomic signaling CM Revankar, CG Bologa, RA Pepermans, G Sharma, WK Petrie, ... Cell chemical biology 26 (12), 1692-1702. e5, 2019 | 17 | 2019 |
| Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ... US Patent 7,875,721, 2011 | 14 | 2011 |
| Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof ER Prossnitz, SE Tkatchenko, CM Revankar, LA Sklar, JB Arterburn, ... US Patent 8,487,100, 2013 | 10 | 2013 |
| A novel screening approach for the dissection of cellular regulatory networks of NF-κB using arrayed CRISPR gRNA libraries P O’Shea, J Wildenhain, M Leveridge, C Revankar, JP Yang, J Bradley, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (6), 618-633, 2020 | 4 | 2020 |
| Abstract LB-112: Unraveling biology and identifying targets with functional genomics approaches using lentiarray crispr libraries CM Revankar, J Braun, JP Yang, J Wetter, T Gokirmak, N Ravinder, ... Cancer Research 79 (13_Supplement), LB-112-LB-112, 2019 | | 2019 |
| Identifying novel and druggable targets in a triple negative breast cancer cell line using the Invitrogen LentiArray Human Kinase CRISPR Library T Gokirmak, J Sharp, C Revankar, DR Piper CANCER RESEARCH 78 (13), 2018 | | 2018 |
| Generation of clonal CRISPR/Cas9-edited human iPSC derived cellular models and its applications in physiologically relevant assays CM Revankar, E Willems, R Lacambacal, T Gokirmak, J Dizon, J Webb, ... CANCER RESEARCH 78 (13), 2018 | | 2018 |
| Abstract LB-067: Identifying novel and druggable targets in a triple negative breast cancer cell line using the Invitrogen LentiArray Human Kinase CRISPR Library T Gokirmak, J Sharp, C Revankar, DR Piper Cancer Research 78 (13_Supplement), LB-067-LB-067, 2018 | | 2018 |
